Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-06-08

Clinical Trial Update: Prospective Genotyping For Total Hip or Knee Replacement Patients Receiving Warfarin (Coumadin) [NA]

View source ↗

Summary

A completed clinical trial evaluating whether prospective genotyping can guide warfarin dosing in patients undergoing total hip or knee replacement.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Warfarin (warfarin)

Snippet

Sponsor: Gwen McMillin | Conditions: Venous Thromboembolism, Bleeding | NA | Status: COMPLETED | Results posted: 2017-06-08